0.0001
0.0000
(0.00%)
At close: April 14 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
38.2060
60.4530
11.1330
5.5460
24.5820
Cost of Revenue
67.6100
85.6100
7.5070
262.6200
22.5400
Gross Profit
-29.4040
-25.1570
3.6260
-257.0740
2.0420
Operating Expense
638.2580
1,248.4690
877.0630
2,225.4000
6,243.7690
Operating Income
-667.6620
-1,273.6260
-873.4370
-2,482.4740
-6,241.7270
Net Non Operating Interest Income Expense
-60.6300
-55.1760
-32.5070
-33.0400
-31.1830
Other Income Expense
--
-3.5490
--
-280.2570
--
Pretax Income
-731.8410
-1,332.3510
-905.9440
-2,795.7710
-6,272.9100
Net Income Common Stockholders
-731.8410
-1,332.3510
-905.9440
-2,795.7710
-6,272.9100
Diluted NI Available to Com Stockholders
-731.8410
-1,332.3510
-905.9440
-2,795.7710
-6,272.9100
Basic EPS
-0.00
-0.00
-0.00
-0.00
-0.03
Diluted EPS
-0.00
-0.00
-0.00
-0.00
-0.03
Basic Average Shares
2,690,640.2260
2,690,640.2260
2,680,730.3330
2,624,071.8160
216,636.1660
Diluted Average Shares
2,690,640.2260
2,690,640.2260
2,680,730.3330
2,624,071.8160
216,636.1660
Total Operating Income as Reported
-585.1900
-1,191.1540
-791.3610
-2,314.9380
-6,121.4340
Total Expenses
705.8680
1,334.0790
884.5700
2,488.0200
6,266.3090
Net Income from Continuing & Discontinued Operation
-731.8410
-1,332.3510
-905.9440
-2,795.7710
-6,272.9100
Normalized Income
-728.2920
-1,328.8020
-905.9440
-2,515.5140
-6,272.9100
Interest Expense
60.6300
55.1760
32.5070
33.0400
31.1830
Net Interest Income
-60.6300
-55.1760
-32.5070
-33.0400
-31.1830
EBIT
-671.2110
-1,277.1750
-873.4370
-2,762.7310
-6,241.7270
EBITDA
-588.7390
-1,194.7030
-791.3610
-2,595.1950
-6,121.4340
Reconciled Cost of Revenue
67.6100
85.6100
7.5070
262.6200
22.5400
Reconciled Depreciation
82.4720
82.4720
82.0760
167.5360
120.2930
Net Income from Continuing Operation Net Minority Interest
-731.8410
-1,332.3510
-905.9440
-2,795.7710
-6,272.9100
Total Unusual Items Excluding Goodwill
-3.5490
-3.5490
--
-280.2570
--
Total Unusual Items
-3.5490
-3.5490
--
-280.2570
--
Normalized EBITDA
-585.1900
-1,191.1540
-791.3610
-2,314.9380
-6,121.4340
12/31/2020 - 11/21/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OWCP OWC Pharmaceutical Research Corp.
0.0001
0.00%
KGET CaliPharms, Inc.
0.0000
-99.00%
CBDL CBD Life Sciences Inc.
0.0003
-25.00%
CVSI CV Sciences, Inc.
0.0300
0.00%
KGKG Kona Gold Beverage, Inc.
0.0002
+100.00%
TEVA Teva Pharmaceutical Industries Limited
13.60
+1.04%
TLRY Tilray Brands, Inc.
0.4868
-0.12%